Complaint against Sun Pharma for anti-trust violations in US

Last Updated: Friday, May 15, 2015, 17:42

Ranbaxy Laboratories, recently acquired by Sunpharma, has been sued in the US District Court in Massachusetts for allegedly manipulating USFDA rules.

Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A: Bankers

Last Updated: Tuesday, April 28, 2015, 11:13

Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.

Nifty rebounds on value-buying, up 52 points

Last Updated: Wednesday, April 22, 2015, 19:54

Bourses snapped its five session losing streak as bouts of value-buying in key Infra, Pharma, banking and Financials lifted the NSE Nifty by 51.95 points to close at 8,429.70.

Sun Pharma shares bounce back, up nearly 2% at close

Last Updated: Wednesday, April 22, 2015, 19:21

Shares of Sun Pharmaceutical Wednesday recovered nearly 2 percent to close at Rs 967.15 on BSE a day after the stock took a severe beating following Daiichi Sankyo selling its entire 9 percent stake in the company for Rs 20,025 crore.

Sun Pharma shares bounce back, up 3% on bourses

Last Updated: Wednesday, April 22, 2015, 13:09

Stocks of Sun Pharmaceutical made a comeback at the bourses Wednesday, rising nearly 3 percent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore.

Nifty falls 70 pts on retrospective tax issue; Sun pharma tanks

Last Updated: Tuesday, April 21, 2015, 22:53

A string of muted corporate earnings and retrospective taxation concerns continued to haunt investors as the NSE Nifty plummeted by 70 points to closed below the key 8,400-mark today.

Sensex at 4-week low, Nifty below 8,400 on Sun Pharma sell-off

Last Updated: Tuesday, April 21, 2015, 18:01

Sun Pharma added to the rout by tumbling more than 8.70 percent on both Sensex and Nifty after Japan's Daiichi Sankyo announced selling of its holding in the Indian drugmaker.

Daiichi Sankyo exits Sun Pharma; ends 7 years of tumultuous ride in India

Last Updated: Tuesday, April 21, 2015, 14:42

The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.

Sun Pharma shares tank 11% as Daiichi completes exit

Last Updated: Tuesday, April 21, 2015, 13:46

Shares of Sun Pharmaceutical on Tuesday plunged nearly 11 percent after Japan's Daiichi Sankyo announced selling its entire holding in the Indian drug major for an estimated Rs 20,420 crore.

Japan's Daiichi completely exits Sun Pharma

Last Updated: Tuesday, April 21, 2015, 12:40

Yesterday, Daiichi Sankyo Company Ltd had announced its decision to sell "the entire or part of its holdings of Sun Pharmaceutical shares..."

Sun Pharma slumps most in near six years on Daiichi's share sale

Last Updated: Tuesday, April 21, 2015, 10:15

Shares of Sun Pharmaceutical Industries Ltd slumped as much as 10.9 percent on Tuesday, heading towards their biggest daily fall since June 2009 after Japan`s Daiichi Sankyo Co Ltd started selling its stake in the Indian drugmaker.

Pharma shares fall; Sun Pharma top loser on Sensex

Last Updated: Thursday, April 9, 2015, 21:45

Pharma shares fell by up to 3.6 percent Thursday amid reports that global brokerage firm Bank of America Merrill Lynch has downgraded some of the drug firms.